Sort
21,281 grants matching “influenza”
Influenza Viral Pathogenesis
$1,748,193Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Regulation of Pathogenic Plasma Cells in Human SLE
$1,747,765Ignacio E. Sanz · Emory University · P01 · FY2020 · AI
Plasma Cells in Health and Disease
$1,747,765Ignacio E. Sanz · Emory University · P01 · FY2020 · AI
Innate Immune Antivirals for Biodefense
$1,746,712Michael J Gale · University Of Washington · R01 · FY2015 · AI
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
$1,744,408David Burkhart · Inimmune Corporation · N01 · FY2023 · AI
Novel mechanisms regulating immunity to respiratory virus infection
$1,742,128Silke Paust · Jackson Laboratory · R01 · FY2025 · AI
Viral Vector Core
$1,741,729Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
VTEU: Phase I Clinical Trial to Evaluate a Universal Influenza Vaccine Candidate
$1,740,342Daniel Hoft · Saint Louis University · N01 · FY2018 · AI
PROTECTIVE AND DAMAGING LYMPHOCYTE RESPONSES IN THE LUNG
$1,736,939Trudeau Institute, Inc. · P01 · FY2002 · HL
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$1,736,476John H Sampson · Duke University · U01 · FY2017 · NS
Immunobiology and Virology of Influenza A Virus
$1,736,392Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
GH13-001, Strengthening Disease Prevention Research Capacity
$1,735,099Celia Cordon-Rosales · University Of The Valley Of Guatemala · U01 · FY2016 · GH
PROTECTIVE AND DAMAGING LYMPHOCYTE RESPONSES IN THE LUNG
$1,732,404Trudeau Institute, Inc. · P01 · FY2001 · HL
LINKING ASSESSMENT AND MEASUREMENT TO PERFORMANCE IN PHEP SYSTEMS (LAMPS)
$1,732,286Kasisomayajula Viswanath · Harvard School Of Public Health · P01 · FY2010 · TP
Clinical and Translational Science Award
$1,731,898Reza Shaker · Medical College Of Wisconsin · UL1 · FY2021 · TR
LINKING ASSESSMENT AND MEASUREMENT TO PERFORMANCE IN PHEP SYSTEMS (LAMPS)
$1,730,974Kasisomayajula Viswanath · Harvard School Of Public Health · P01 · FY2009 · TP
HT-Film-Array: a system to assess respiratory viruses with emphasis on influenza
$1,729,147Steven F Dobrowolski · Biofire Defense, Llc. · U01 · FY2008 · AI
P1-Genomic determinants of epidemic success in respiratory viruses
$1,728,873Adam Lauring · University Of Michigan At Ann Arbor · U19 · FY2024 · AI
Toward a Universal Influenza Virus Vaccine
$1,728,808Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,728,446Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2018 · AI
Discovery of Adjuvants that Direct T-cell Fates for Improved Safety and Efficacy in Vaccines Against Influenza and Tuberculosis
$1,724,791Aaron Esser-Kahn · University Of Chicago · N01 · FY2025 · AI
1/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)
$1,723,433Fernando D Martinez · University Of Arizona · UH3 · FY2024 · HL
Small-molecule adjuvants to enhance the efficacy of flu vaccines in newborns and the elderly
$1,722,927Ofer Levy · Boston Children'S Hospital · N01 · FY2019 · AI
Systems Biology Program
$1,722,906Michael G Katze · University Of Washington · N01 · FY2013 · AI
VACCINE AND TREATMENT EVALUATION UNITS
$1,721,918Kathryn Margaret Edwards · Vanderbilt University · N01 · FY2013 · AI